BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20819749)

  • 1. [Prostanoids in the treatment of pulmonary arterial hypertension].
    Başkurt M; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin therapies for the treatment of pulmonary arterial hypertension.
    Gomberg-Maitland M; Olschewski H
    Eur Respir J; 2008 Apr; 31(4):891-901. PubMed ID: 18378784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension.
    Mubarak KK
    Respir Med; 2010 Jan; 104(1):9-21. PubMed ID: 19683911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled prostanoids in the therapy of pulmonary hypertension.
    Gessler T; Seeger W; Schmehl T
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):1-12. PubMed ID: 18518827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin and its analogues in the treatment of pulmonary hypertension.
    Olschewski H; Rose F; Schermuly R; Ghofrani HA; Enke B; Olschewski A; Seeger W
    Pharmacol Ther; 2004 May; 102(2):139-53. PubMed ID: 15163595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
    Gomberg-Maitland M; Preston IR
    Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pulmonary arterial hypertension: the role of prostacyclin and prostaglandin analogs.
    Safdar Z
    Respir Med; 2011 Jun; 105(6):818-27. PubMed ID: 21273054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension.
    Theo Schermuly R; Ardeschir Ghofrani H; Weissmann N
    Curr Top Dev Biol; 2005; 67():251-84. PubMed ID: 15949537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension.
    John J; Palevsky H
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):197-205. PubMed ID: 22115402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of pulmonary hypertension].
    Illaro Uranga A; Ibarra Barrueta O; Oribe Ibáñez M; Lertxundi Etxebarría U; Corcostegui Santiago B; Iglesias Lambarri A; Santos Ibáñez A
    Farm Hosp; 2004; 28(4):275-85. PubMed ID: 15369438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pathophysiology and therapy of pulmonary hypertension.
    Olschewski H; Rose F; Grünig E; Ghofrani HA; Walmrath D; Schulz R; Schermuly R; Grimminger F; Seeger W
    J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostanoid therapy for pulmonary arterial hypertension.
    Strauss WL; Edelman JD
    Clin Chest Med; 2007 Mar; 28(1):127-42; ix. PubMed ID: 17338932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapeutic management of pulmonary arterial hypertension.
    Anderson JR; Nawarskas JJ
    Cardiol Rev; 2010; 18(3):148-62. PubMed ID: 20395700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.
    Bishop BM; Mauro VF; Khouri SJ
    Pharmacotherapy; 2012 Sep; 32(9):838-55. PubMed ID: 22806762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
    Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
    Matthes J; Mathen F; Herzig S; Wassermann K
    Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.